Cancer
Cancer Ongoing 2021 North Shore NSW

B8011011

A Phase 1b/2 Open Label Umbrella Study of Sasanlimab Combined With Anti-Cancer Therapies Targeting Multiple Molecular Mechanisms in Participants With Non-Small Cell Lung Cancer (NSCLC).

Trial overview

Disease
Lung cancer
Topic
B8011011
Eligibility criteria

Non-Small Cell Lung Cancer, please enquire for further details.

Study details

While on treatment there will be regular blood tests and scans to monitor progress. At completion of treatment the study will continue to follow your progress.

Further information

For more information regarding this clinical trial click here.

Location

North Shore NSW